Technology & Telecommunication Services » Software | Decision Diagnostics Corp.

Decision Diagnostics Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
5,367.70
1,841.00
2,206.20
2,967.40
2,991.40
2,240.20
Other Funds
46.50
31.00
-
77.50
-
945.90
Funds from Operations
3,509.50
1,465.70
1,566.50
2,047.10
1,852.40
1,294.30
Changes in Working Capital
468.60
10.20
537.70
483.00
293.50
28.60
Net Operating Cash Flow
3,041.00
1,476.00
1,028.80
2,530.10
1,558.90
1,322.90
Capital Expenditures
79.60
237.00
485.60
317.80
114.60
Net Investing Cash Flow
79.60
237.00
485.60
317.80
114.60
Issuance/Reduction of Debt, Net
1,495.00
709.40
307.70
1,567.70
985.50
Net Financing Cash Flow
4,146.30
844.90
307.70
3,627.70
1,410.50
Net Change in Cash
7,107.70
868.00
1,206.80
779.90
263.10
Free Cash Flow
3,041.00
1,476.00
1,243.80
2,830.10
1,623.80
Change in Capital Stock
2,604.80
104.50
-
2,137.50
425.00

About Decision Diagnostics

View Profile
Address
2660 Townsgate Road
Los Angeles California 91361
United States
Employees -
Website http://www.decisiondiagnostics.com
Updated 07/08/2019
Decision Diagnostics Corp. engages in prescription and non-prescription diagnostics and home testing products. It offers blood glucose home testing devices including Genstrip50 and GenUltimate test strips, as well as three exciting new concepts for blood testing monitors. The decision diagnostics also provides smart phone based electronic medical record applications which allow physicians to carry access and update their patients' histories, medication data and best care guidelines at the point of care.